Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318624 | SCV000849856 | likely benign | Inborn genetic diseases | 2017-02-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000908789 | SCV001053569 | benign | not provided | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000908789 | SCV001839748 | benign | not provided | 2019-08-13 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253592 | SCV002524709 | benign | ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002253592 | SCV002798603 | likely benign | ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder | 2021-11-18 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000908789 | SCV005209955 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003918173 | SCV004731365 | likely benign | ADNP-related disorder | 2019-05-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |